Ezetimibe alone for over 75 years old as a primary prevention to decrease cardiovascular events
{{output}}
The EWTOPIA 75 (Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older) study supports the reduction in the risk of atherosclerotic cardiovascular disease (ASCVD) events with ezetimibe without statin therapy in pe... ...
